Expression of p53 & epidermal growth factor receptor in glioblastoma

被引:6
|
作者
Karnam, Sameera
Kottu, Radhika [1 ]
Chowhan, Amit Kumar
Bodepati, Prasad Chandramouleswara
机构
[1] Sri Venkateswara Inst Med Sci, Dept Pathol, Alipiri Rd, Tirupati 517507, Andhra Pradesh, India
关键词
Epidermal growth factor receptor; glioblastoma; immunohistochemistry; p53; ASTROCYTOMA PROGRESSION; GENE AMPLIFICATION; MULTIFORME; MUTATIONS; PROTEIN; EGFR; HETEROZYGOSITY; CLASSIFICATION; POPULATION; PATHWAYS;
D O I
10.4103/ijmr.IJMR_1179_15
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Glioblastoma (GB) is the most frequent brain tumour, manifesting at any age, with a peak incidence between 45 and 75 years. Primary and secondary GBs constitute relatively distinct disease entities in evolution, in expression profiles and in therapeutic response. Histopathologically, primary and secondary GBs are indistinguishable. The aim of this investigation was to study the immunohistochemical (IHC) expression of p53 and epidermal growth factor receptor (EGFR) in GB with the objective of categorizing the morphological variants of GB into primary and secondary based on the presence of low-grade areas and knowing the variable expression of p53 and EGFR in primary and secondary GB. Methods: A total of 28 patients with GB were studied and categorized into primary and secondary based on the presence of low-grade areas, i.e. discernible astrocytic morphology, gemistocyte and oligodendroglia. Tumours with the presence of combination of the above features or any one of the above features were taken as secondary GB, whereas tumours with highly pleomorphic areas were considered as primary GB. IHC was done on the representative tissue blocks for p53 and EGFR. Results: Majority of the patients were in the fifth and sixth decades of life with a mean age of 46.96 +/- 13 yr with male preponderance (male:female 2.5:1). Mean age of presentation was 48.93 +/- 12 yr in primary and 44.69 +/- 15 yr in secondary GB. All cases of GB were classified into primary (53.57%) and secondary (46.43%) based on morphology. EGFR was more frequently expressed than p53. Based on IHC, 50 per cent of cases were classified into primary, three per cent into secondary and 47 per cent as unclassified. Interpretation & conclusions: Histopathological features, i.e. presence of low-grade areas, may play a role in classifying GB into primary and secondary. EGFR has a pivotal role in gliomagenesis. Combination of p53 and EGFR alone may not be sufficient to clarify GB into primary and secondary.
引用
收藏
页码:738 / 745
页数:8
相关论文
共 50 条
  • [1] p53 mutation and epidermal growth factor receptor overexpression in glioblastoma
    Yoon, KS
    Lee, MC
    Kang, SS
    Kim, JH
    Jung, S
    Kim, YJ
    Lee, JH
    Ahn, KY
    Lee, JS
    Cheon, JY
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (04) : 481 - 488
  • [2] Assessment of expression of epidermal growth factor receptor and p53 in meningiomas
    Narla, Swetha
    Uppin, Megha S.
    Saradhi, M. Vijaya
    Sahu, B. P.
    Purohit, A. K.
    Sundaram, C.
    [J]. NEUROLOGY INDIA, 2014, 62 (01) : 37 - 41
  • [3] Protein expression status of p53 and epidermal growth factor receptor in thymoma
    Cui, Fe
    He, Jianxing
    Liu, Jun
    Chen, Yijiang
    [J]. ONCOLOGY LETTERS, 2011, 2 (03) : 459 - 463
  • [4] p53 homologue p63 represses epidermal growth factor receptor expression
    Nishi, H
    Senoo, M
    Nishi, KH
    Murphy, B
    Rikiyama, T
    Matsumura, Y
    Habu, S
    Johnson, AC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) : 41717 - 41724
  • [5] EPIDERMAL GROWTH-FACTOR RECEPTOR AND P53 PROTEIN EXPRESSION IN HUMAN GLIOBLASTOMAS
    KORDEK, R
    BIERNAT, W
    ALWASIAK, J
    YANAGIHARA, R
    LIBERSKI, PP
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 1995, 2 (05) : 487 - 491
  • [6] P53 PROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN HUMAN ASTROCYTOMAS
    KORDEK, R
    BIERNAT, W
    ALWASIAK, J
    MACULEWICZ, R
    YANAGIHARA, R
    LIBERSKI, PP
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1995, 26 (01) : 11 - 16
  • [7] Worse Outcome in Primary Glioblastoma Multiforme With Concurrent Epidermal Growth Factor Receptor and p53 Alteration
    Ruano, Yolanda
    Ribalta, Teresa
    de Lope, Angel Rodriguez
    Campos-Martin, Yolanda
    Fiano, Concepcion
    Perez-Magan, Elisa
    Hernandez-Moneo, Jose-Luis
    Mollejo, Manuela
    Melendez, Barbara
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (02) : 257 - 263
  • [8] Correlation between p53 and epidermal growth factor receptor expression in breast cancer classification
    Wang, X. Z.
    Liu, Q.
    Sun, J. J.
    Zuo, W. S.
    Hu, D. W.
    Ma, S. G.
    Mu, D. B.
    Yu, Z. Y.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 4282 - 4290
  • [9] Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients
    Simmons, ML
    Lamborn, KR
    Takahashi, M
    Chen, PC
    Israel, MA
    Berger, MS
    Godfrey, T
    Nigro, J
    Prados, M
    Chang, S
    Barker, FG
    Aldape, K
    [J]. CANCER RESEARCH, 2001, 61 (03) : 1122 - 1128
  • [10] Epidermal growth factor receptor and p53 expression in a large series of gliosarcomas: A tissue microarray study
    Reed, R. C.
    Born, D. E.
    [J]. MODERN PATHOLOGY, 2007, 20 : 300A - 300A